查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1554203

醫療仿生技術市場規模、佔有率、趨勢分析報告：按類型、應用、區域、細分市場預測，2024-2030

Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

醫學仿生技術市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球醫學仿生技術市場規模預計將達到553.6億美元，2024年至2030年複合年成長率為7.6%。

奈米技術的進步、對義肢和植入的需求不斷增加、與醫學仿生技術相關的研發活動的增加以及主要市場參與者的策略活動是推動市場成長的主要因素。例如，2021年4月，curasan AG擴大了在歐洲的銷售網路，該公司將Silesia Dental和Implants Diffusion International SARL納入其歐洲銷售網路。

影響角膜的疾病是全世界失明的最重要原因。據世界衛生組織稱，每年約有 200 萬新發角膜失明病例。全球有超過 3000 萬人因角膜疾病或受傷而導致一隻或雙眼失明，有些人視力喪失。創造可靠、穩健和擴充性的人工角膜解決方案的許多嘗試都失敗了。因此，存在未滿足的需求，並且正在進行研究和開發工作，以尋找負擔得起且持久的病理、損傷和角膜失明的解決方案。例如，2022 年3 月，印度理工學院海得拉巴分校LV Prasad 眼科研究所的研究人員將生產一種由廢棄的人類角膜製成的新產品，可用於治療角膜疤痕，這是導致角膜失明的主要原因。

在醫療仿生技術市場，許多公司正在新興市場拓展產品。例如，最重要的新進展是，2021年11月，Osteopore的智慧3D仿生支架在中國獲得了專利。該技術是與新加坡南洋理工大學的科學家共同開發的，並於 2021 年初獲得了歐洲專利。該專利預計將在中國市場創造許多研發機會，使該公司能夠利用當地的專業知識作為其產品開發過程的一部分。

COVID-19大流行預計將對醫療仿生技術市場的成長產生負面影響。 COVID-19 大流行對尋求牙科護理的患者數量產生了相當大的影響。總體而言，約旦醫院接受治療的患者人數減少了約 90.4%（從 17,591 人減少至 1,689 人）。因此，在 COVID-19 大流行期間，這些技術的使用較少。

此外，隨著事故數量的增加，仿生學在整形外科的引入預計將蓬勃發展。根據國際安全道路旅行協會的數據，全球每年約有 2,000 萬至 5,000 萬人遭受殘疾傷害。因此，這些因素預計將對醫療仿生技術市場的成長產生正面影響。

另一方面，嚴格的法律規範正在阻礙醫學仿生技術產業的發展。隨著仿生生物材料的應用日益增加並在許多醫學領域受到歡迎，對其的準確評估非常重要。儘管每種生醫材料都經過徹底的上市前評估，但監管機構每年都會收到大量不利事件和併發症的報告。此外，由於生物材料被納入生物系統，因此它們必須滿足所有科學要求，例如高生物相容性、足夠長的保存期限以及與生物相互作用的相容性。

醫學仿生技術市場報告亮點

  • 在醫學仿生技術市場中，按類型分類，心血管領域佔最大佔有率。這是因為對心血管疾病的研究活動的增加和調查數量的增加預計將增加仿生技術的採用並擴大醫學仿生技術市場。
  • 預計創傷治療領域在預測期內將呈指數級成長。手術病例數量的增加和慢性病的全球流行增加了對創傷治療和創傷護理產品的需求。
  • 由於奈米技術的重大發展促進了使用基於仿生技術的設備進行高效和精確的非載體藥物輸送，醫療仿生技術市場的藥物輸送領域預計將以最快的速度成長。充足的資金和研發的進步將促進醫學仿生技術市場的成長。
  • 由於高研發投入、新產品的市場開拓以及該地區政府的大力資助，北美在 2023 年將主導全球醫療仿生技術市場。
  • 由於慢性病盛行率不斷上升以及主要市場參與者業務的擴張，預計亞太地區未來幾年將顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章醫學仿生技術市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 醫學仿生技術市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 醫學仿生技術市場：依類型估算及趨勢分析

  • 細分儀表板
  • 醫療仿生技術市場：類型變異分析，2023 年和 2030 年
  • 心血管
  • 整形外科
  • 眼科

第5章 醫學仿生技術市場：依應用估算與趨勢分析

  • 細分儀表板
  • 醫療仿生技術市場：2023 年和 2030 年應用變化分析
  • 傷口癒合
  • 組織工程
  • 藥物輸送
  • 其他用途

第6章 醫學仿生技術市場：區域估計與趨勢分析

  • 2023 年及 2030 年醫療仿生技術市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Otsuka Medical Devices Group
    • Stryker
    • Abbott
    • AVINENT Science and Technology
    • SynTouch Inc.
    • Osteopore International Pte Ltd
    • Vandstrom, Inc.
    • Biomimetics Technologies Inc
    • Swedish Biomimetics 3000 ApS
    • Keystone Dental Group
    • LifeMatrix
    • Curasan, Inc.
    • CorNeat Vision
簡介目錄
Product Code: GVR-4-68039-995-0

Medical Biomimetics Market Growth & Trends:

The global medical biomimetics market size is expected to reach USD 55.36 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.

The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.

On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.

Medical Biomimetics Market Report Highlights:

  • By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
  • The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
  • The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
  • North America dominated the global medical biomimetics market in 2023 due to the high R&D investment, development of novel products, and strong funding from the government in the region
  • The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Biomimetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Biomimetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Biomimetics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Biomimetics Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Cardiovascular
    • 4.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orthopedic
    • 4.4.1. Orthopedic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Ophthalmology
    • 4.5.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Medical Biomimetics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Medical Biomimetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Wound Healing
    • 5.3.1. Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Tissue Engineering
    • 5.4.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Delivery
    • 5.5.1. Drug Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Other Applications
    • 5.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Medical Biomimetics Market: Regional Estimates & Trend Analysis

  • 6.1. Medical Biomimetics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Otsuka Medical Devices Group
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Stryker
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Abbott
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. AVINENT Science and Technology
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. SynTouch Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Osteopore International Pte Ltd
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Vandstrom, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Biomimetics Technologies Inc
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Swedish Biomimetics 3000 ApS
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Keystone Dental Group
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. LifeMatrix
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Curasan, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. CorNeat Vision
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives